Sign Up to like & get
recommendations!
1
Published in 2020 at "Stem Cell Reports"
DOI: 10.1016/j.stemcr.2020.09.003
Abstract: Previous studies reported safety and applicability of Mesenchymal Stem/Stromal Cells (MSC) to ameliorate pulmonary inflammation in ARDS. Thus, multiple clinical trials assessing the potential of MSC for COVID-19 treatment are underway. Yet, as SARS-inducing corona…
read more here.
Keywords:
state inflammatory;
steady state;
inflammatory conditions;
msc ... See more keywords